Boris Aleil

1.8k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Boris Aleil is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Boris Aleil has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Hematology and 8 papers in Internal Medicine. Recurrent topics in Boris Aleil's work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Platelet Disorders and Treatments (6 papers). Boris Aleil is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Platelet Disorders and Treatments (6 papers). Boris Aleil collaborates with scholars based in France, Switzerland and Germany. Boris Aleil's co-authors include Christian Gachet, Jean‐Pierre Cazenave, Wolfram Jochum, Yinghua Tian, Rolf Graf, Pierre–Alain Clavien, Michael Bäder, Mickaël Lesurtel, Diego J. Walther and Catherine Ravanat and has published in prestigious journals such as Science, Blood and Stroke.

In The Last Decade

Boris Aleil

21 papers receiving 1.3k citations

Hit Papers

Platelet-Derived Serotonin Mediates Liver Regeneration 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Aleil France 11 565 505 302 282 243 22 1.3k
Hirotaka Isobe Japan 15 169 0.3× 186 0.4× 342 1.1× 48 0.2× 87 0.4× 29 1.2k
Monique Philippe France 19 549 1.0× 300 0.6× 93 0.3× 69 0.2× 14 0.1× 27 1.5k
Fumihiro Sanada Japan 22 331 0.6× 360 0.7× 42 0.1× 82 0.3× 22 0.1× 42 1.4k
Jane Mitchell United States 14 441 0.8× 349 0.7× 574 1.9× 10 0.0× 170 0.7× 16 1.7k
Firdos Ahmad United Arab Emirates 22 400 0.7× 191 0.4× 196 0.6× 14 0.0× 36 0.1× 104 1.6k
M.A.A. Kratzer Germany 12 197 0.3× 106 0.2× 177 0.6× 25 0.1× 60 0.2× 31 673
Soichiro Usui Japan 23 509 0.9× 363 0.7× 22 0.1× 122 0.4× 11 0.0× 111 1.7k
Jane F. Arthur Australia 18 481 0.9× 273 0.5× 764 2.5× 5 0.0× 133 0.5× 24 1.5k
Yasuko Kawano Japan 12 371 0.7× 183 0.4× 37 0.1× 53 0.2× 10 0.0× 20 1.3k
Kensaku Nishihira Japan 19 460 0.8× 403 0.8× 171 0.6× 4 0.0× 82 0.3× 94 1.3k

Countries citing papers authored by Boris Aleil

Since Specialization
Citations

This map shows the geographic impact of Boris Aleil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Aleil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Aleil more than expected).

Fields of papers citing papers by Boris Aleil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Aleil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Aleil. The network helps show where Boris Aleil may publish in the future.

Co-authorship network of co-authors of Boris Aleil

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Aleil. A scholar is included among the top collaborators of Boris Aleil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Aleil. Boris Aleil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertoletti, Laurent, Y. Benhamou, Yannick Béjot, et al.. (2018). Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Reviews. 32(4). 272–279. 16 indexed citations
2.
Dillinger, Jean‐Guillaume, Boris Aleil, S. Cheggour, et al.. (2017). Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases. 111(2). 85–94. 25 indexed citations
3.
Aleil, Boris, et al.. (2015). Enquête prospective sur les nouveaux anticoagulants oraux en médecine libérale : un enthousiasme prudent. Annales de Cardiologie et d Angéiologie. 64(2). 68–75. 2 indexed citations
4.
Schwein, Adeline, Anne Lejay, S. Gærtner, et al.. (2014). Aortitis and Aortic Occlusion in Crohn Disease. Annals of Vascular Surgery. 29(2). 365.e5–365.e9. 4 indexed citations
5.
Lejay, Anne, Fabien Thaveau, Boris Aleil, et al.. (2013). Platelet Antiaggregation Therapy and Subinguinal Endovascular Revascularization. Annals of Vascular Surgery. 27(5). 621–626. 1 indexed citations
6.
Stéphan, Dominique, et al.. (2011). Thrombose de la veine ovarienne. La Presse Médicale. 41(5). 550–551.
7.
Aleil, Boris, Laurent Jacquemin, F. De Poli, et al.. (2008). Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 1(6). 631–638. 103 indexed citations
8.
Léon, Catherine, Anita Eckly, Béatrice Hechler, et al.. (2007). Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood. 110(9). 3183–3191. 134 indexed citations
9.
Lesurtel, Mickaël, Rolf Graf, Boris Aleil, et al.. (2006). Platelet-Derived Serotonin Mediates Liver Regeneration. Science. 312(5770). 104–107. 603 indexed citations breakdown →
10.
Gachet, Christian, Béatrice Hechler, Christelle Nonne, et al.. (2006). Athérothrombose : transposition des modèles à la clinique et réciproquement. Therapies. 61(5). 389–394. 3 indexed citations
11.
Aleil, Boris. (2006). La glycoprotéine V soluble plaquettaire. Archives des Maladies du Coeur et des Vaisseaux - Pratique. 2006(153). 10–10. 1 indexed citations
12.
Meyer, Nicolás, Valérie Wolff, Daniel Kientz, et al.. (2006). Plasma glycoprotein V levels in the general population: Normal distribution, associated parameters and implications for clinical studies. Thrombosis and Haemostasis. 96(10). 505–511. 15 indexed citations
13.
Cazenave, Jean‐Pierre, Hervé Isola, Christian Gachet, & Boris Aleil. (2005). Actualités en transfusion sur la conservation des plaquettes. Transfusion Clinique et Biologique. 12(2). 226–229. 2 indexed citations
14.
Gachet, Christian & Boris Aleil. (2005). [The inter-individual variability of the response to clopidogrel].. PubMed. 98(3). 216–25. 8 indexed citations
16.
Aleil, Boris & Christian Gachet. (2005). Protéine VASP. Archives des Maladies du Coeur et des Vaisseaux - Pratique. 2005(138). 10–10. 1 indexed citations
17.
Wolff, Valérie, Boris Aleil, Maurice Giroud, et al.. (2005). Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke. Stroke. 36(3). e17–9. 18 indexed citations
18.
Aleil, Boris, et al.. (2004). La glycoprotéine V soluble : un nouveau marqueur plasmatique de la thrombose artérielle. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
19.
Aleil, Boris, et al.. (2004). Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. Journal of Thrombosis and Haemostasis. 3(1). 85–92. 297 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026